Article
Novel therapies in melanoma.
Immunotherapy - 1 Dec 2011
Scheier Benjamin, Amaria Rodabe, Lewis Karl, Gonzalez Rene
Abstract excerpt
The incidence of cutaneous melanoma is on the rise worldwide despite increasing awareness and vigilance towards prevention by the lay public and health professionals. Melanoma is easily curable by surgical excision when detected early, but it is nearly incurable when discovered in its later stages owing to resistance to treatment. Unfortunately, treatment options traditionally used in melanoma have not shown a...
Topics
- Antibodies, Monoclonal
- CTLA-4 Antigen
- Drug Approval
- Drug Resistance, Neoplasm
- Humans
- Immunity
- Indoles
- Ipilimumab
- MAP Kinase Signaling System
- Melanoma
- Molecular Targeted Therapy
- Mutation